About Vax Before Cancer
Vax-Before-Cancer is a research-based, cancer vaccine news publisher that is ‘fact-checked’ by doctors, nurses, and pharmacists.
Our worldwide publishing network is focused on cancer, a disease that impacts most families around the world. Over the past 20 years, innovative scientists have brought cancer-preventing vaccines and immunotherapies through the FDA’s rigorous clinical study process that are saving lives today.
Healthcare providers can now administer preventive vaccines to people to keep certain cancers from developing, such as the Human Papolivirus (HPV). To be effective, a healthy person has to get the HPV vaccine before the virus infects him or her. Otherwise, the HPV vaccine will not prevent certain cancers.
Other cancer vaccines, also called therapeutic vaccines, including immunotherapy, threat people after being diagnosed with cancer. These vaccines work to boost the body's natural defenses to fight cancer, such as targeting specific antigens that are given to people whose tumors have those antigens on the surface of the tumor cells.
And, there are many innovative vaccines candidates in clinical studies. The number of active compounds in development has grown to over 3,500, with the majority of those testing programs are focused on the T-cell-targeted immunomodulators.
Researchers are testing vaccines and immunotherapies for several types of cancers, including:
- Bladder cancer: Researchers are studying the effectiveness of a vaccine made from a virus modified to contain HER2 cells.
- Brain tumors: There are many studies testing treatment vaccines aimed at certain molecules on the surface of brain tumor cells.
- Breast cancer: Several studies are testing treatment vaccines for breast cancer, given alone or with other therapies.
- Cervical cancer: The FDA has approved cervical cancer prevention vaccines.
- Colorectal cancer: Researchers are creating treatment vaccines that encourage the body to attack cells with antigens thought to cause colorectal cancer.
- Kidney cancer: Researchers are testing the use of several cancer vaccines to treat kidney cancer. They are also testing vaccines to prevent later-stage kidney cancer from recurring.
- Leukemia: Studies are looking at treatment vaccines for various types of leukemia, such as acute myeloid leukemia and chronic lymphocytic leukemia.
- Lung cancer: Lung cancer treatment vaccines in clinical trials target antigens.
- Melanoma: Researchers are testing destroying melanoma cells and antigens in the vaccines encourage the immune system to destroy other melanoma cells in the body.
- Pancreatic cancer: Researchers are working on several treatment vaccines designed to boost the immune system’s response to pancreatic cancer cells.
- Prostate cancer: Sipuleucel-T is a vaccine doctors use to treat men with metastatic prostate cancer. Now researchers are studying if the vaccine can help men with less advanced prostate cancer.
Vax-Before-Cancer Mission Statement
Publish ‘fact-checked’ cancer information that empowers patients and healthcare providers to make informed vaccination decisions.
Vax-Before-Cancer.com is a digital publisher of news related to the cancer vaccines. Vax-Before-Cancer is an owned and operated affiliate of the Precision Vax, LLC network, which includes Precision Vaccinations, Zika News and Vax-Before-Travel.
The weekly Vax-Before-Cancer newsletter is sent to your email address containing the latest information. Registration is free for this insightful publication.
Vax-Before-Cancer syndicates its news articles into Facebook, which you can easily "Like", "Share" or "Subscribe"
Vax-Before-Cancer publishes news based on research from universities, government agencies, pharmaceutical manufacturers, the CDC, and the WHO. These organizations have no influence on the published content.
Our news-gathering team is independent of commercial or political interests. We do not accept gifts, including paid travel, in order to avoid any conflict-of-interest or appearance thereof. We cite potential conflicts of interest on the same page as the published, relevant work.
If you have any questions contact, please contact our publisher at [email protected].
Vax-Before-Cancer Medical Advisory Team
The Medical Advisory Team works closely with our editorial team to ensure Vax-Before-Cancer published content is accurate, actionable, and understandable. We seek diverse voices in our reporting staff. If you have any questions, please contact Dr. Robert Carlson, [email protected].
Our news organization commits its best efforts to publish accurate information. We stand by the information we publish, and if it’s not correct, we will change it as quickly as possible.
We take many steps to ensure accuracy, such as:
- We investigate claims with skepticism; question assumptions; challenge conventional wisdom
- We confirm information with subject-matter experts and seek to corroborate what sources tell us by talking with other informed people or consulting documents
- We verify content, such as technical terms, stats, etc, against source documents or make clear who is providing the information. We may share relevant components of a story with a primary source or an outside expert to verify them
Inclusiveness is at the heart of thinking and acting as journalists. The complex issues we face as a society require respect for different viewpoints. Race, class, generation, gender, and geography all affect point of view. Reflecting these differences in our reporting leads to better, more nuanced stories and a better-informed community.
If our digital audiences cannot trust us to get the small things right, how can they trust us on the big things?
We welcome feedback from our readers regarding the information that we publish. Our news organization is committed to telling readers when an error has been made, the magnitude of the error and the correct information, as quickly as possible. This commitment to transparency is applicable to small errors as well as large.
Please send any suggested changes to Vax-Before-Cancer's President, [email protected].
Terms of Service: By using our website, you signify your assent to these Terms and Conditions. If you do not agree to all of these Terms and Conditions of Use, please do not use this site. All information on this site is provided "as-is" for informational purposes only and is not a substitute for medical advice or treatment. You should consult with a medical professional if you have any questions about your health. The use of any information on this site is solely at your own risk. Vax-Before-Cancer may revise and update these Terms and Conditions at any time. Your continued usage of this website means you accept all changes.
Corrections: Vax-Before-Cancer is committed to making clarifications to its content when appropriate. We take prompt action to edit even minor errors like spelling, grammar, or stylistic changes. Because style changes do not change the meaning of the content, those kinds of "style" changes will be updated on our site without notice.
Editorial: We are committed to publishing information on various immunization topics. We rely on you, our reader, to choose the information that is most appropriate for your needs. Information located on Vax-Before-Cancer should not be used as a substitute for professional healthcare advice.
Advertising: Vax-Before-Cancer accepts advertising from third parties ("Advertisers"), which may include third party banners, badges, contextual advertising and content created or provided by an Advertiser (collectively referred to as "Advertisements" or "Advertising"). We have regularly sought sponsorships and advertisements from relevant commercial organizations, manufacturers, and other health leaders. These sponsorships, which are a form of advertising, enable us to provide you with our trusted content at no cost.
Vax-Before-Cancer Ownership Structure
Vax-Before-Cancer is owned by PrecisionVax, LLC, which is a woman-owned, digital news network, founded in 2016. Karen McClorey Hackett, the president of PrecisionVax is committed to transparency in our ownership structure and revenue sources.
We produce our revenues from advertising. Our dominant advertiser is Google Adsense. Vax-Before-Cancer also has lead generation business agreements with GoodRx for discounts, Antidote clinical trials, Ulta Labs for diagnostic tests, and various healthcare providers for vaccine appointment requests.
Our editorial team has no relationship, nor communications, with any advertiser. If you have any questions please contact [email protected].
Comments and Concerns
We believe that public feedback is not a one-way street. Instead, we are committed to engaging with you and taking action based on your suggestions, complaints and other feedback. We will respond to your request asap. Please send an email to [email protected].
Karen Hackett, President